Early research (Phase 1)Active Not RecruitingNCT06454175
What this trial is testing
A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years
Who this might be right for
HPV InfectionHPV-Related CarcinomaGenital Wart+1 more
Shanghai Bovax Biotechnology Co., Ltd. 72